The French Competition Authority (FCA) has adopted an innovative merger decision in the health care institution sector, assessing not only the effects of the operation on medical services (diagnostic and treatments), but also the effects on non-medical ancillary services. An innovative merge clearance decision in the healthcare institutions’ sector The decision has not been published yet (press release of 23 July 2017). The operation
The French Competition Authority adopts an innovative merger decision in the healthcare institution sector assessing not only the effects on medical services but also non-medical ancillary services (Médipôle-Partenaires / Elsan)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.